| HOME >> MEDICINE >> TECHNOLOGY |
CHAPTER FIVE: THE GLOBAL PHARMACEUTICAL AND GENERICS
MARKET 48
GLOBAL GENERICS MARKET 48
MAIN NATIONAL GENERICS MARKETS 49
TABLE 5 WORLD PHARMA AND GENERICS MARKETS, THROUGH
2016 ($ BILLIONS) 49
TABLE 6 CURRENT AND FORECAST NATIONAL GENERICS
MARKETS, THROUGH 2016 ($ BILLIONS) 50
MARKET OPPORTUNITIES BY PRODUCT CLASS 50
LEADING GENERIC MOLECULES 50
TABLE 7 WIDELY PRESCRIBED GENERIC MOLECULES IN THE US
AND EUROPE 50
TABLE 7 (CONTINUED) 51
Anti-infectives 51
Anti-infectives (Continued) 52
TABLE 8 LEADING ANTI-INFECTIVE PRODUCTS SALES
ESTIMATES WITH YEAR OF PATENT EXPIRY, 2010 ($ BILLIONS) 53
CNS Therapies 54
TABLE 9 CNS MARKET BY MAJOR INDICATIONS, 2010 ($
BILLIONS) 54
FIGURE 1 CNS MARKET SHARES BY MAJOR INDICATIONS, 2010
(%) 55
Antidepressants 55
Antipsychotics 56
TABLE 10 LEADING CNS PRODUCT SALES ESTIMATES, 2010 ($
BILLIONS) 57
Anxiolytics 57
Sleep Disorders 58
Epilepsy 58
Parkinson's Disease 59
Migraine 59
Cardiovascular Products 60
TABLE 11 LEADING CARDIOVASCULAR PRODUCT SALES, 2009 ($
BILLIONS) 61
Anti-arthritis Products 62
Steroids 62
NSAIDs 63
COX- II Inhibitors 63
DMARDs 64
TABLE 12 LEADING ANTI-ARTHRITIS PRODUCT SALES
ESTIMATES, 2009 ($ BILLIONS) 65
Respiratory Products 66
Asthma 66
COPD 66
Allergic Rhinitis 67
Allergic … (Continued) 68
TABLE 13 LEADING RESPIRATORY PRODUCT SALES ESTIMATES,
2009 ($ BILLIONS) 69
Drugs Used to Treat Asthma and COPD 69
Bronchodilators 69
Inhaled Bronchodilators 69
Anticholinergics 70
Oral Bronchodilators 70
Leukotriene Antagonists 70
Steroids 71
FIGURE 2 USAGE OF MAIN PRODUCT CATEGORIES BASED
REVENUES (%) 71
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |